Autologous Transplantation of Muscle Precursor Cells Modified with a Lentivirus for Muscular Dystrophy: Human Cells and Primate Models

This publication has 35 references indexed in Scilit:

• Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells
  Molecular Therapy, 2006
• Nucleofection of muscle-derived stem cells and myoblasts with ϕC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts
  Molecular Therapy, 2004
• Dystrophin Expression in Myofibers of Duchenne Muscular Dystrophy Patients Following Intramuscular Injections of Normal Myogenic Cells
  Molecular Therapy, 2004
• Cellular and Molecular Regulation of Muscle Regeneration
  Physiological Reviews, 2004
• Autotransplantation in mdx Mice of mdx Myoblasts Genetically Corrected by an HSV-1 Amplicon Vector
  Cell Transplantation, 2002
• Transfection of large plasmids in primary human myoblasts
  Gene Therapy, 2001
• Efficient non-viral DNA-mediated gene transfer to human primary myoblasts using electroporation
  Neuromuscular Disorders, 2001
• Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts
  Gene Therapy, 1998
• Dystrophin: The protein product of the duchenne muscular dystrophy locus
  Cell, 1987
• Defective myoblasts identified in Duchenne muscular dystrophy.
  Proceedings of the National Academy of Sciences, 1983